Stuart Chaussee & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Hold |
317
| – | – | 0.03% | 57 |
|
|
2025
Q1 | $138K | Hold |
317
| – | – | 0.03% | 44 |
|
|
2024
Q4 | $117K | Hold |
317
| – | – | 0.03% | 50 |
|
|
2024
Q3 | $165K | Hold |
317
| – | – | 0.04% | 34 |
|
|
2024
Q2 | $172K | Hold |
317
| – | – | 0.05% | 31 |
|
|
2024
Q1 | $164K | Hold |
317
| – | – | 0.05% | 33 |
|
|
2023
Q4 | $149K | Buy |
317
+85
| +37% | +$40.1K | 0.04% | 34 |
|
|
2023
Q3 | $101K | Hold |
232
| – | – | 0.03% | 33 |
|
|
2023
Q2 | $103K | Hold |
232
| – | – | 0.03% | 35 |
|
|
2023
Q1 | $107K | Hold |
232
| – | – | 0.04% | 29 |
|
|
2022
Q4 | $119K | Hold |
232
| – | – | 0.04% | 29 |
|
|
2022
Q3 | $105K | Hold |
232
| – | – | 0.24% | 22 |
|
|
2022
Q2 | $112K | Hold |
232
| – | – | 0.24% | 22 |
|
|
2022
Q1 | $114K | Hold |
232
| – | – | 0.05% | 31 |
|
|
2021
Q4 | $108K | Hold |
232
| – | – | 0.05% | 33 |
|
|
2021
Q3 | $86K | Hold |
232
| – | – | 0.13% | 26 |
|
|
2021
Q2 | $89K | Hold |
232
| – | – | 0.04% | 32 |
|
|
2021
Q1 | $83K | Buy |
+232
| New | +$83K | 0.03% | 41 |
|